Quebec confirms first case of blood clot after administration of AstraZeneca vaccine

Quebec Premier François Legault speaks at a press conference on March 18, 2021.

|| []).push(function () { viAPItag.display(“vi_1088641796”) })

The health ministry says measures are in place, the person has been treated and is recovering, and the AstraZeneca vaccine is safe.

Content of the article

The Quebec Ministry of Health says it is fully ready “to quickly take care of a person showing symptoms (of a blood clot) following a vaccination”, adding that the measures already in place have enabled the authorities to detect the first such cases in the province.

The Ministry of Health “confirms that the first case (of a post-vaccination blood clot) occurred in Quebec in recent days and after the administration of the vaccine (AstraZeneca)”, according to a statement released by the ministry on Tuesday afternoon.

“The person was treated by the health network and received appropriate care. They are now recovering at home and there is no fear for their lives. “

AstraZeneca’s COVID-19 vaccine “is a safe vaccine even if there are rare embolisms or problems” with blood clots, public health director Horacio Arruda said at a press conference in Quebec on Tuesday. “It’s still part of our, I would say, good tools” to fight COVID-19, he said.

Content of the article

Quebecers should not worry because the situation is under control due to “hyper-vigilance” of health professionals, said Minister of Health Christian Dubé.

“We knew it could happen, and the likelihood is there,” Dubé told reporters in Quebec.

Blood clots “are considered a possible complication of a vaccine but remain very rare, approximately one case in 100,000 doses administered,” recalled Tuesday the Ministry of Health.

Quebec has always recognized the importance of safe vaccines and the health of those who receive them, the ministry said, adding that it has “a very effective vaccine surveillance system” and great expertise in the field.

“For a person 55 and over, the risk of COVID-19 infections and the development of complications is much higher than (the risk of blood clots) from the vaccine,” the ministry wrote.

“This incident does not call into question its use in this age group. Please note that the AstraZeneca vaccine is only given to people aged 55 to 79 years. “

All our coronavirus news is available at

Sign up for our newsletter dedicated to local COVID-19 coverage at

Help support our local journalism by subscribing to the Montreal Gazette here.

|| []).push(function () { viAPItag.display(“vi_1088641796”) })


Please enter your comment!
Please enter your name here